Parkinson's disease

News

Biomarker hailed as “game changer” in Parkinson’s

Researchers have discovered a new biomarker for Parkinson’s that could be used to identify people at risk of the disease and profoundly change the way it is treated.

News

FDA rejects AbbVie’s continuous Parkinson’s therapy

Delay could narrow the gap between AbbVie's product and a rival system from Mitsubishi Tanabe.

News

Digital tech assessed in BlueRock Parkinson’s trial

Devices that remotely monitor patients' mobility and sleep will be put through their paces.

Digital

Newel Health begins next phase of development of Soturi

Soturi, Newel Health’s digital therapeutics solution for Parkinson’s Disease (PD), has begun the next phase of development, aiming to v

Digital

Newel Health scores $2.5M from MJFF for Parkinson’s app

Newel Health has been awarded a $2.5 million USD grant from the Michael J.

Digital

Partner Content

Newel Health awarded $2.5M Michael J. Fox research grant

Newel Health has been awarded a $2.5 million research grant from The Michael J. Fox Foundation.

Biomarker hailed as “game changer” in Parkinson’s

FDA rejects AbbVie’s continuous Parkinson’s therapy

Digital tech assessed in BlueRock Parkinson’s trial

Newel Health begins next phase of development of Soturi

Newel Health scores $2.5M from MJFF for Parkinson’s app

Newel Health awarded $2.5M Michael J. Fox research grant

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Parkinson's disease

Editor's Picks